BPG is committed to discovery and dissemination of knowledge
JOURNAL HOME
Number of total visits
33510545
Number of visits today
3587
Number of downloads
16697273
MEMBERSHIP
BPG JOURNALS
Cited by in F6Publishing
For: Xian J, Liang D, Zhao C, Chen Y, Zhu Q. TRIM21 inhibits the osteogenic differentiation of mesenchymal stem cells by facilitating K48 ubiquitination-mediated degradation of Akt. Experimental Cell Research 2022. [DOI: 10.1016/j.yexcr.2022.113034] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Pan Y, Tang Y, Gu H, Ge W. Ubiquitin modification in osteogenic differentiation and bone formation: From mechanisms to clinical significance. Front Cell Dev Biol 2022;10:1033223. [DOI: 10.3389/fcell.2022.1033223] [Reference Citation Analysis]
2 Huang N, Sun X, Li P, Liu X, Zhang X, Chen Q, Xin H. TRIM family contribute to tumorigenesis, cancer development, and drug resistance. Exp Hematol Oncol 2022;11:75. [PMID: 36261847 DOI: 10.1186/s40164-022-00322-w] [Reference Citation Analysis]
3 Zeng R, Xiong Y, Lin Z, Panayi AC, Sun Y, Cao F, Liu G, Deng R. E3 Ubiquitin Ligases: Potential Therapeutic Targets for Skeletal Pathology and Degeneration. Stem Cells International 2022;2022:1-13. [DOI: 10.1155/2022/6948367] [Reference Citation Analysis]
Write to the Help Desk
© 2004-2023 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345